Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Antiviral Therapy|February 14, 2019
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatmentMariantonietta Pisaturo, Mario Starace, Carmine Minichini, et al.
Scientific Reports|January 26, 2019
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access programVincenza Calvaruso, Chiara Mazzarelli, Laura Milazzo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2019
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL studyMarcello Persico, Andrea Aglitti, Michele Milella, et al.
Advances in Therapy|October 29, 2024
Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated CirrhosisMarkus Cornberg, Dietrich Hüppe, Christoph Sarrazin, et al.
European Journal of Haematology|November 6, 2025
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer CentersMarco Picardi, Annamaria Vincenzi, Claudia Giordano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 12, 2023
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohortLoreta A Kondili, Maria Giovanna Quaranta, Luisa Cavalletto, et al.
Journal of Hepatology|February 14, 2017
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinomaGiuseppe Cabibbo, Salvatore Petta, Marco Barbara, et al.
Frontiers in Medicine|June 12, 2023
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter studyOliviero Riggio, Ciro Celsa, Vincenza Calvaruso, et al.
Viruses|May 25, 2024
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)Maria Giovanna Quaranta, Luisa Cavalletto, Francesco Paolo Russo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 12, 2020
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational studyAlessio Aghemo, Alfredo Alberti, Pietro Andreone, et al.
Pageof 14